
    
      Patients: consecutively referred for HSC mobilization. 12 to 18 days after the previous
      chemotherapy. No haematological growth factor during the 8 previous days.

      Mobilization: one sc injection of 200 Âµg/kg pegfilgrastim (Neulasta, Amgen) Evaluation during
      the study: CD34 circulating cells from day 3 to day 7 ; AE recording Judgment criterion:
      percentage of children achieving at least 5x10e6 CD34 cells with a standard apheresis (less
      than 3 blood volume processed) Analysis: sequential Bayesian study
    
  